Product Code: ETC7744362 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Oral Anti-Diabetic Drug Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Oral Anti-Diabetic Drug Market - Industry Life Cycle |
3.4 Japan Oral Anti-Diabetic Drug Market - Porter's Five Forces |
3.5 Japan Oral Anti-Diabetic Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Japan Oral Anti-Diabetic Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Japan |
4.2.2 Growing elderly population in Japan |
4.2.3 Technological advancements in oral anti-diabetic drugs |
4.2.4 Rising awareness about diabetes management |
4.2.5 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with oral anti-diabetic drugs |
4.3.3 Potential side effects of oral anti-diabetic medications |
4.3.4 Competition from alternative diabetes treatment options |
4.3.5 Limited access to healthcare services in rural areas |
5 Japan Oral Anti-Diabetic Drug Market Trends |
6 Japan Oral Anti-Diabetic Drug Market, By Types |
6.1 Japan Oral Anti-Diabetic Drug Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Biguanides, 2021- 2031F |
6.1.4 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Alpha-glucosidase inhibitors, 2021- 2031F |
6.1.5 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Dopamine-D2 receptor agonists, 2021- 2031F |
6.1.6 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Sodium-glucose Cotransport-2 (SGLT-2) inhibitor, 2021- 2031F |
6.1.7 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, 2021- 2031F |
6.1.8 Japan Oral Anti-Diabetic Drug Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
7 Japan Oral Anti-Diabetic Drug Market Import-Export Trade Statistics |
7.1 Japan Oral Anti-Diabetic Drug Market Export to Major Countries |
7.2 Japan Oral Anti-Diabetic Drug Market Imports from Major Countries |
8 Japan Oral Anti-Diabetic Drug Market Key Performance Indicators |
8.1 Average time to market for new oral anti-diabetic drugs |
8.2 Patient adherence rate to oral anti-diabetic drug therapy |
8.3 Number of clinical trials conducted for oral anti-diabetic drugs |
8.4 Percentage of diabetic patients using oral anti-diabetic drugs in Japan |
8.5 Rate of hospital readmissions for diabetic patients using oral anti-diabetic drugs |
9 Japan Oral Anti-Diabetic Drug Market - Opportunity Assessment |
9.1 Japan Oral Anti-Diabetic Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Japan Oral Anti-Diabetic Drug Market - Competitive Landscape |
10.1 Japan Oral Anti-Diabetic Drug Market Revenue Share, By Companies, 2024 |
10.2 Japan Oral Anti-Diabetic Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |